Tirzepatide GLP-1 medication is known to improve sleep apnea for people with both obstructive sleep apnea (OSA) and obesity, but not all patients benefit equally. Now, new research presented at the 2026 ATS International ...
May 19, 2026
0
9
Biomedical engineers at Duke University have developed a new approach to delivering GLP-1 medications orally that does not require fasting and maintains their efficacy. The technique could also be useful for any pharmaceutical ...
May 19, 2026
0
8
For many women with lipedema, the diagnosis comes after years of being told the same thing: eat less, not more. The problem is that the fat accumulating around their hips and legs isn't responding to diet or exercise, because ...
May 19, 2026
0
4
A text-messaging intervention can improve patient activation and cardiovascular risk behaviors in adults with psoriasis, according to a study published online May 13 in JAMA Dermatology.
May 19, 2026
0
3
In November 2025, the White House announced pricing deals with multiple pharmaceutical manufacturers to lower domestic prices for glucagon-like peptide-1 receptor agonist drugs (GLP-1RAs) including Ozempic, Wegovy, Mounjaro, ...
May 18, 2026
0
9
Obesity has long been the invisible health crisis looming over humanity, with rates climbing globally. There is some positive news now emerging from a multi-decade study spanning several nations. A recent study published ...
New research published in JAMA Network Open suggests that there is a positive association between GLP-1 agonists—drugs commonly used to treat obesity and diabetes—and better outcomes among breast cancer patients.
May 17, 2026
0
24
As every parent knows, an infant's early life is a series of milestones, from logging every development to regular checkups with the pediatrician to monitor body length, head circumference, and weight.
May 17, 2026
0
8
Tougher regulation on peptide supplies is needed as illegal use skyrockets among young Australians, University of Queensland researchers say. Dr. Timothy Piatkowski, of UQ's School of Public Health, said the country's regulatory ...
May 16, 2026
0
16
New research presented at the European Congress on Obesity (ECO2026) in Istanbul, Turkey (12–15 May) shows that following treatment with GLP-1 drugs for obesity, most weight loss is fat mass (80–85%) and relative muscle mass ...
May 16, 2026
0
15
